emtricitabine has been researched along with AIDS Dementia Complex in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Brown, TT; Landay, A; Masters, MC; Miyahara, S; Robertson, K; Taiwo, BO; Vecchio, A | 1 |
Huang, Y; Qin, Z; Qiu, L; Wang, Y; Xu, P; Zhang, M; Zheng, JC | 1 |
1 trial(s) available for emtricitabine and AIDS Dementia Complex
Article | Year |
---|---|
Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Biomarkers; Darunavir; Double-Blind Method; Emtricitabine; Female; HIV Infections; Humans; Inflammation; Male; Maraviroc; Ritonavir; Tenofovir | 2020 |
1 other study(ies) available for emtricitabine and AIDS Dementia Complex
Article | Year |
---|---|
Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro.
Topics: AIDS Dementia Complex; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cell Proliferation; Emtricitabine; Mice; Mice, Inbred C57BL; Neural Stem Cells; Raltegravir Potassium; Tenofovir | 2017 |